Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer have?
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer has 48 citations in the OpenAlex counts ScholarIQ stores.
When was Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer published?
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer has 2023 year in the ScholarIQ index.
What is the open-access status of Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer?
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer has closed oa status in the ScholarIQ index.
What is the DOI of Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer?
The DOI for Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer is on the source record.
What is the PMID of Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer?
The PMID for Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer is on the source record.
What is the OpenAlex record for Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer?
The OpenAlex for Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer is on the source record.